Global Search

Search articles, concepts, and chapters

J GlaucomaMay 202211 citations

Efficacy of Combined Phacoemulsification and Goniosynechialysis in Primary Angle Closure Disease With Different Degrees of Peripheral Anterior Synechiae.

Wei Liqing, Fu Lin, Nie Li, Lian Hengli, Qian Zhenbin, Liang Yuanbo, Pan Weihua


AI Summary

Phaco-GSL effectively lowers IOP in angle-closure glaucoma regardless of initial PAS extent, but larger PAS requires more intraoperative separation and has higher recurrence.

Abstract

Prcis: Phacoemulsification and goniosynechialysis (Phaco-GSL) was equally effective in the treatment of primary angle-closure disease (PACD) with preoperative peripheral anterior synechiae (PAS) <180 degrees and larger than 180 degrees. Patients with a larger preoperative PAS range required more range of mechanical separation intraoperatively and displayed more recurrence of PAS (re-PAS) range postoperatively.

Purpose

To evaluate the long-term efficacy of combined phaco-GSL in PACD with different extent of PAS.

Patients and methods: A retrospective study was conducted on 67 patients (79 eyes) who received phaco-GSL. The patients were divided into 2 groups according to the extent of PAS (group A: PAS ≤180 degrees; group B: PAS >180 degrees). Changes in intraocular pressure (IOP), the number of anti-glaucoma drugs, intraoperative mechanical separation of PAS and range of re-PAS during the last follow-up ≥12 months were analyzed.

Results

At baseline, eyes in group B presented with higher IOP and more anti-glaucoma drugs usage ( P =0.008 and 0.004). The PAS range, IOP, number of anti-glaucoma medication were reduced both in 2 groups at the final visit. The range of mechanical separation intraoperatively and re-PAS postoperatively were both larger in group B ( P =0.002 and <0.001). The postoperative re-PAS range was positively correlated with the range of mechanical separation ( R2 =0.17). The complete success rates at 12, 24, 36, and 48 months were 86.8%, 71.1%, 71.1%, and 71.1% in group A; and 80.5%, 74.6%, 69.9%, and 69.9% in group B. The qualified success rates were 100%, 96.6%, 92.0%, and 92.0% in group A; and 100%, 89.5%, 85.1%, and 85.1% in group B.

Conclusion

Phaco-GSL for the treatment of PACD showed equally effective IOP control regardless of the extent of preoperative PAS.


MeSH Terms

Corneal DiseasesEye AbnormalitiesGlaucoma, Angle-ClosureHumansIntraocular PressureIris DiseasesPhacoemulsificationRetrospective StudiesTissue AdhesionsTreatment Outcome

Key Concepts6

Phacoemulsification and goniosynechialysis (Phaco-GSL) was equally effective in the treatment of primary angle-closure disease (PACD) with preoperative peripheral anterior synechiae (PAS) <180 degrees and larger than 180 degrees.

Comparative EffectivenessCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch13Ch45

Patients with primary angle-closure disease (PACD) and a larger preoperative peripheral anterior synechiae (PAS) range (>180 degrees) required more range of mechanical separation intraoperatively during phacoemulsification and goniosynechialysis (Phaco-GSL) and displayed more recurrence of PAS (re-PAS) range postoperatively.

PrognosisCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch13Ch45

The range of mechanical separation intraoperatively and recurrence of peripheral anterior synechiae (re-PAS) postoperatively were both larger in group B (PAS >180 degrees) (P =0.002 and <0.001, respectively) compared to group A (PAS ≤180 degrees) in patients undergoing phacoemulsification and goniosynechialysis (Phaco-GSL) for primary angle-closure disease (PACD).

PrognosisCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch13Ch45

The postoperative recurrence of peripheral anterior synechiae (re-PAS) range was positively correlated with the range of mechanical separation (R2 =0.17) in patients undergoing phacoemulsification and goniosynechialysis (Phaco-GSL) for primary angle-closure disease (PACD).

PrognosisCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch13Ch45

The complete success rates for phacoemulsification and goniosynechialysis (Phaco-GSL) in primary angle-closure disease (PACD) at 12, 24, 36, and 48 months were 86.8%, 71.1%, 71.1%, and 71.1% in patients with PAS ≤180 degrees (group A); and 80.5%, 74.6%, 69.9%, and 69.9% in patients with PAS >180 degrees (group B).

TreatmentCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch13Ch45

At baseline, eyes in group B (PAS >180 degrees) presented with higher intraocular pressure (IOP) (P =0.008) and more anti-glaucoma drugs usage (P =0.004) compared to group A (PAS ≤180 degrees) in patients undergoing phacoemulsification and goniosynechialysis (Phaco-GSL) for primary angle-closure disease (PACD).

DiagnosisCohortRetrospective Cohort Studyn=67 patients (79 eyes)Ch3Ch13Ch29

Is this article assigned to the wrong chapter(s)? Let us know.